← Back to Search

Patient Priorities Care for Multiple Chronic Conditions

N/A
Recruiting
Led By Lilian N. Dindo, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
3 active health problems on active problem list or prescribed 10 medications
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 month follow-up
Awards & highlights

Study Summary

This trial will compare the effect of Patient Priorities Care with usual care on reducing treatment burden, increasing priorities-aligned home and community services, and setting shared health outcome goals.

Who is the study for?
This trial is for older veterans with multiple chronic conditions who have had at least two medical appointments in the past 18 months, are on ten or more medications, and have three active health issues. They must be able to give informed consent and not be expected to pass away within a year. Those with severe mental illness, dementia, substance abuse, complete hearing loss, frequent no-shows for appointments, nursing home residents or those needing a translator are excluded.Check my eligibility
What is being tested?
The study compares Patient Priorities Care—a method focusing on patients' personal health priorities and reducing treatment burden—with usual care among veterans. Participants will be randomly assigned to either approach to see if it better aligns treatments with their life goals and reduces healthcare strain.See study design
What are the potential side effects?
Since this trial involves care approaches rather than medication, traditional side effects aren't applicable. However, there may be emotional or psychological impacts from discussing personal priorities and confronting one's own health decisions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have 3 active health issues or am taking 10 medications.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Home and Community Services Use
Patient Reported Treatment Burden
Secondary outcome measures
Ambulatory Care Utilization
Patients' goal setting
shared decision making

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Patient Priorities CareExperimental Treatment1 Intervention
A facilitator will schedule a PPC facilitation encounter 2-3 weeks before an upcoming PCP visit. The facilitator conducts a structured assessment using a written conversation guide that begins with general questions establishing what is most important to Veterans about their health and moves toward establishing specific goals (actionable outcomes), and what patients are willing/not willing to do to achieve these goals (care preferences). The result is a structured patient priorities report delivered to PCPs designed to facilitate changes in the patient's care plan to align it with his/her priorities. In the subsequent visit, the PCP will use one or more of the established PPC decisional strategies to align care with patients' priorities. Education for PCPs about the facilitation process, the patient priorities report, and the decisional strategies occurs prior to the PCP seeing any intervention patients. The PCP will document changes in care made to achieve the identified priorities.
Group II: Usual CarePlacebo Group1 Intervention
PCPs will not be alerted when an encounter involves a UC group participant. UC participant visits will appear the same as all other unenrolled patient encounters. UC participants will not receive any additional preparation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Priorities Care
2016
N/A
~420

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,304,884 Total Patients Enrolled
Lilian N. Dindo, PhDPrincipal InvestigatorMichael E. DeBakey VA Medical Center, Houston, TX
2 Previous Clinical Trials
213 Total Patients Enrolled
Aanand Dinkar Naik, MD BAPrincipal InvestigatorMichael E. DeBakey VA Medical Center, Houston, TX

Media Library

Patient Priorities Care Clinical Trial Eligibility Overview. Trial Name: NCT04922320 — N/A
Multiple Chronic Conditions Research Study Groups: Patient Priorities Care, Usual Care
Multiple Chronic Conditions Clinical Trial 2023: Patient Priorities Care Highlights & Side Effects. Trial Name: NCT04922320 — N/A
Patient Priorities Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04922320 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have signed up to take part in this clinical trial?

"Affirmative. According to records on clinicaltrials.gov, this ongoing trial was first posted on September 15th 2022 and recently updated the next day. Currently, 366 patients are needed across two medical sites for enrolment in the study."

Answered by AI

What is the main purpose of this research endeavor?

"Researchers will monitor the main outcome of this four-month research effort, Patient Reported Treatment Burden. Secondary goals include a discourse analysis to identify changes in care that adhere to patient preferences and values (using audio recordings gathered from forty patients), gauging whether health decisions were collaborative with Goal Setting using the Older Patient Assessment of Chronic Illness Care score as well as Shared Decision Making via the CollaboRATE scale."

Answered by AI

Are there any opportunities to join this research initiative?

"Per the latest information on clinicaltrials.gov, this experimental treatment is currently seeking participants to enrol. The protocol was posted and last updated on September 15th and 16th respectively in 2022."

Answered by AI
Recent research and studies
~38 spots leftby Jun 2024